Upload
holly-ferguson
View
214
Download
1
Embed Size (px)
Citation preview
Communicable Disease Surveillance & Response WHO-WPRO
Pandemic (H1N1) 2009 situation Pandemic (H1N1) 2009 situation and response in the Western and response in the Western
Pacific RegionPacific Region
Takeshi KasaiTakeshi KasaiCommunicable Disease Surveillance and Response, Communicable Disease Surveillance and Response,
Western Pacific Regional OfficeWestern Pacific Regional OfficeWorld Health Organization World Health Organization
Communicable Disease Surveillance & Response WHO-WPRO
WPRO Response-Risk AssessmentWPRO Response-Risk Assessment
VirologicalMutation
InterventionContainment to Mitigation
ImpactHealth Care
ImpactSociety
ClinicalDevelop guideline
Epidemiological Prediction & Set up reference
Action Oriented Risk Assessment
Communicable Disease Surveillance & Response WHO-WPRO
Number of Countries/Areas Reporting Confirmed Number of Countries/Areas Reporting Confirmed Pandemic (H1N1) 2009 Cases to WPRO by WeekPandemic (H1N1) 2009 Cases to WPRO by Week
0
5
10
15
20
25
30
17 18 19 20 21 22 23 24 25 26 27 28 29 30
Epidemiological Week
Num
ber
of C
ount
ries/
Are
as
South Hemisphere North Hemisphere Tropical Pacific
Communicable Disease Surveillance & Response WHO-WPRO
Seasonal influenza and Pandemic (H1N1) 2009 Situation in WPRO
North Hemisphere
Not yet in flu season, low ILI activity but higher compared to previous years
Number of cases is gradually increasing Pandemic (H1N1) 2009 is widely distributed geographically
South Hemisphere
In the middle of flu season. Laboratory test results are predominantly Pandemic (H1N1) 2009
rather than seasonal influenza Spread is higher compared to seasonal influenza Shows signs of slowing virus activity
Tropics Seasonal Influenza activity is getting higher compared to previous
years Pandemic (H1N1) 2009 activity is continuing
Pacific 18 out of 21 countries/areas have reported cases of Pandemic
(H1N1) 2009 Fiji and Samoa has reported near 100 cases as of Aug 13 2009.
Communicable Disease Surveillance & Response WHO-WPRO
Pandemic (H1N1) 2009 Fatal CasesPandemic (H1N1) 2009 Fatal CasesWestern Pacific RegionWestern Pacific Region
Total Deaths Total Deaths 136136
Clinical picturesClinical pictures (N=48)(N=48)75% - with underlying medical 75% - with underlying medical condition condition 3 deaths among pregnant, all without 3 deaths among pregnant, all without underlying medical conditionunderlying medical condition
Clinical Course Clinical Course (N=27)(N=27)9 days - median interval from onset of 9 days - median interval from onset of symptoms to death (range: 4-14)symptoms to death (range: 4-14)5 days - median interval from onset of 5 days - median interval from onset of symptoms to hospitalization (range: 2-symptoms to hospitalization (range: 2-8)8)3 days – median interval from 3 days – median interval from hospitalization to death (range: 2-9)hospitalization to death (range: 2-9)
Final diagnosis Final diagnosis (N=42)(N=42)62% - severe pneumonia62% - severe pneumonia14% - congestive heart failure14% - congestive heart failure12% - ARDS12% - ARDS
Confirmed case-deaths associated with pandemic(H1N1) by Age Group WPR, 2009
0.0
4.21.5
12.510.4
6.3
2.1 2.1
6.3
16.7
25.0
12.5
0.0
5.0
10.0
15.0
20.0
25.0
30.0
<4 5-14 15-19 20-39 40-64 65+
Age Group
Communicable Disease Surveillance & Response WHO-WPRO
Influenza Virus TypingInfluenza Virus Typing
# o
f re
po
rte
d c
ase
s
Week
JapanJapanWeek 19-32Week 19-3220092009
New ZealandNew ZealandAugust 2009August 2009
Communicable Disease Surveillance & Response WHO-WPRO
Reported Cases of Oseltamivir Resistance
Country/Country/areasareas
TamifluTamiflu DetailDetail
1 Denmark Prophylaxis Contact with traveller.
Developed symptoms on 5th day of prophylaxis
Index: Sensitive
No further cases were indentified.
2 Japan
40s, F
Prophylaxis Developed symptoms on 7th day of prophylaxis
Index: Sensitive
No further cases were indentified.
3 HK, 16 F None Travelled from San Francisco
4 Japan Young child
Prophylaxis Developed symptoms on 4th day of prophylaxis
Index: Sensitive
No further cases were indentified.
5 Canada
59 M
Prophylaxis Developed symptoms during prophylaxis
Index: Sensitive
6 Japan
30s, M
Prophylaxis Developed symptoms on 6th day of prophylaxis
Index: Sensitive
No further cases were indentified.
7 Japan No Young child
Prophylaxis Developed symptoms on 7th day of prophylaxis
Index: Sensitive
No further cases were indentified.
8 Singapore 28F
Treatment Travelled to New Caledonia, Hawaii. Isolates showed mutation on 3 rd day of treatment
Data as of 13 Aug
Communicable Disease Surveillance & Response WHO-WPRO
Surveillance & Response StrategiesSurveillance & Response Strategies
Strategy Strategy No No Community TransmissionCommunity Transmission
WithWithCommunity TransmissionCommunity Transmission
ContainmentContainment Example: Example: Mongolia Mongolia Resource intensive andResource intensive and
minimal public health minimal public health benefitbenefit
MitigationMitigation Lost opportunity to delay Lost opportunity to delay the spreadthe spread
Example: Example: Australia, Australia, Japan, New ZealandJapan, New Zealand
Communicable Disease Surveillance & Response WHO-WPRO
Cases with Travel HistoryCases with Travel HistoryPhilippines and AustraliaPhilippines and Australia
AustraliaAustralia
Country and areasCountry and areas # of cases# of cases
FijiFiji 11
Viet NamViet Nam 77
South KoreaSouth Korea 11
SamoaSamoa 11
Hong Kong, ChinaHong Kong, China 2121
New ZealandNew Zealand 22
Taiwan, ChinaTaiwan, China 33
MalaysiaMalaysia 3232
Mainland, ChinaMainland, China 1414
SingaporeSingapore 2222
TOTALTOTAL 9595
PhilippinesPhilippines
Country and areasCountry and areas # of cases# of cases
Macao, ChinaMacao, China 55
PNGPNG 11
Saudi ArabiaSaudi Arabia 22
Taiwan, ChinaTaiwan, China 11
MalaysiaMalaysia 88
South KoreaSouth Korea 22
Mainland, ChinaMainland, China 55
SingaporeSingapore 1010
JapanJapan 1010
Hong Kong, ChinaHong Kong, China 77
TOTALTOTAL 5050
Communicable Disease Surveillance & Response WHO-WPRO
Monitoring of Pandemic ImpactMonitoring of Pandemic Impact
Pandemic impact still remains Pandemic impact still remains uncertain and is currently under uncertain and is currently under monitoring monitoring
Pandemic impact on a Pandemic impact on a population has many population has many dimensions: health, social and dimensions: health, social and economic consequenceseconomic consequences
No severe impact on health-care No severe impact on health-care services as a result of acute services as a result of acute respiratory disease reportedrespiratory disease reported
Pressures on local hospitals and Pressures on local hospitals and potential economic loss reported potential economic loss reported in some countriesin some countries
Pademuc impact indicators reported in the Western Pacific Region
4 4
00
1
2
3
4
5
Low Moderate Severe
Degree of disruption of health-care services as a result of acute
respiratory disease
Nunb
er o
f cou
ntrie
s &
area
s
Communicable Disease Surveillance & Response WHO-WPRO
WPRO ResponseWPRO Response
Risk Management (1)•Communication•Rapid Gap Assessment•Guideline development
Risk Management (2)•Technical Support
Risk Assessment•IHR•MS information•Surveillance
Framework for Action
Communicable Disease Surveillance & Response WHO-WPRO
APSED AND WORKPLAN APSED AND WORKPLAN
IHR (Public Health Emergencies of International Concern)
Asia Pacific Strategy for Emerging Diseases (APSED)
Bi-Regional Workplan
AvianInfluenza
Pandemic preparedness
Communicable Disease Surveillance & Response WHO-WPRO
Framework for ActionFramework for Action
SURVEILLANCE
COMMAND
PUBLIC HEALTH INTERVENTIONS
COMMUNICATIONHEALTH CARE
RESPONSEHEALTH SECTOR
How to slow down transmission
How to improve care and reduce deaths
Laboratory
PA
RT
NE
RS
INDIVIDUAL LEVEL SOCIETAL LEVEL
Communicable Disease Surveillance & Response WHO-WPRO
H5 ResponseH5 Response
H5H5
BIRDS HUMANInterfaceInterface
Information SharingInformation Sharing
SurveillanceSurveillance
RapidRapid ResponseResponse
Monitoring of PigsMonitoring of Pigs
PIGS
H1
New ResponseNew Response
H1
H1 Pandemic ResponseH1 Pandemic Response
H5
Re-assortment
Re-assortment
Monitoring of humanMonitoring of human
Diagram Showing Responses to Reduce Probability of Viral Re-assortment
Communicable Disease Surveillance & Response WHO-WPRO
ConclusionConclusion
Epidemiological Situation differs by countryEpidemiological Situation differs by country Virus has not undergone any significant mutation Virus has not undergone any significant mutation
and majority of cases have been mild. However, and majority of cases have been mild. However, severe and death cases have been reported in severe and death cases have been reported in countries with sustained community countries with sustained community transmission. transmission.
For those who have not yet experienced For those who have not yet experienced extensive community transmission, it is extensive community transmission, it is important to prepare both national and local important to prepare both national and local levels as much as possible. levels as much as possible.
WPRO-SEARO have developed a Framework WPRO-SEARO have developed a Framework for Action to assist preparations with the goal to for Action to assist preparations with the goal to minimize preventable deathsminimize preventable deaths